Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Mirna Therap (MIRN)

Mirna Therap (MIRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 35,671
  • Shares Outstanding, K 20,860
  • Annual Sales, $ 0 K
  • Annual Income, $ -26,270 K
  • 60-Month Beta 3.67
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.76
Trade MIRN with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.25
  • Most Recent Earnings N/A on N/A
  • Latest Earnings Date 08/21/17
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.45 +17.93%
on 08/21/17
1.76 -2.84%
on 08/01/17
+0.03 (+1.79%)
since 07/25/17
3-Month
1.40 +22.14%
on 05/26/17
1.91 -10.47%
on 07/14/17
+0.25 (+17.12%)
since 05/25/17
52-Week
1.12 +52.68%
on 11/03/16
3.12 -45.19%
on 08/29/16
-1.35 (-44.12%)
since 08/25/16

Business Summary

Mirna Therapeutics, Inc. is a biopharmaceutical company which develops microRNA-based oncology therapeutics. The Company's pipeline products include MRX34, miR-Rxlet-7, miR-Rx06, miR-Rx07 and miR-Rx16 which are in preclinical trials. Its lead product, MRX34, is a liposome-encapsulated miR-34 mimic indicated...

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 1.80
1st Resistance Point 1.76
Last Price 1.71
1st Support Level 1.66
2nd Support Level 1.60
3rd Support Level N/A

See More

52-Week High 3.12
Fibonacci 61.8% 2.36
Fibonacci 50% 2.12
Fibonacci 38.2% 1.88
Last Price 1.71
52-Week Low 1.12

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar